Buy & Sell Hormel Foods Corp (HRL) – Hormel Foods Corp Price Today
Aura AI Summary
Key Stats
- $13.57BMarket Cap
- Consumer StaplesSector
- -14.43%3M Drawdown
- $15.56BEnterprise Value
- 4.75%Dividend Yield
- 1% Buy | 99% SellTrading Activity
- 100 daysTypical Hold Time
Hormel Foods Corp (HRL) is currently valued at a market capitalization of $13.57B, with an enterprise value of $15.56B. Over the past 52 weeks, Hormel Foods Corp has traded between a low of $19.74 and a high of $31.54, highlighting its annual price range. Over the past three months, Hormel Foods Corp has recorded a drawdown of -14.43%, reflecting recent price volatility. Hormel Foods Corp offers a dividend yield of 4.75%, with the most recent dividend of $0.29 paid on 13 Apr 26. On average, investors hold Hormel Foods Corp for approximately 100 days, indicating typical investor behavior on the platform.
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Most Recent News
Batmobile Racing unveils new car design with Fasoul and Lightec for Lamborghini Super Trofeo Asia at Fuji Speedway
Batmobile Racing has revealed a striking new car design for the Lamborghini Super Trofeo Asia race at Fuji Speedway, supported by new partnerships with Fasoul and Lightec. Leading the Pro category, drivers William Tregurtha and Jonathan Cecotto aim t...
Pepeto presale surges amid Bitcoin price optimism and new exchange tech rollout.
Pepeto's presale is rapidly advancing, attracting significant attention as its exchange and cross-chain bridge near completion. The project uses secure lock and mint technology to enable token swaps across Ethereum, BNB Chain, and Solana, promising z...
Biogen to acquire RayThera for up to $1B, boosting immunology pipeline with new drug candidates.
Biogen has agreed to acquire RayThera Inc. for up to $1 billion, including upfront and milestone payments. This acquisition adds multiple anti-inflammatory drug candidates to Biogen's immunology portfolio, with the lead asset expected to enter Phase ...
